Innovent Biologics, Inc. (HKG:1801)
Hong Kong
· Delayed Price · Currency is HKD 97.50
+1.50 (1.56%)
Aug 15, 2025, 4:08 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 166.99 billion as of August 15, 2025. Its market cap has increased by 154.78% in one year.
Market Cap
166.99B
Enterprise Value
161.62B
Revenue
10.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
97.50
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 166.99B, an increase of 800.77%. That is a compound annual growth rate of 38.20%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 266.94B |
| Hansoh Pharmaceutical Group Company | 223.44B |
| JD Health International | 175.53B |
| Akeso | 147.38B |
| Sino Biopharmaceutical | 136.28B |
| WuXi Biologics | 125.45B |
| CSPC Pharmaceutical Group | 119.48B |
| Sichuan Kelun-Biotech Biopharmaceutical | 99.10B |